UEG's content platform for gastroenterology education bringing recordings, courses, guidelines, and more together in one place.

Re-live UEG Week 2026 on Gutflix Gut Guide online What's new on Gutflix

Trending on Gutflix

Rate for better recommendations!

Your feedback helps us show you more of what you like and less of what you dislike!

More of this!

We will show you more similar content.

Not for me!

We won't suggest this again.

Bookmark!

Save this content for later!

New to myUEG? Create an account! Log In with myUEG account

UEG Poster

Standard Poster

Share via Email Share on Facebook Share on X Share on LinkedIn Share on Bluesky

This content is part of Gutflix. Log in with your myUEG account, or create one free, to watch it.

Not sure what you can access? Learn more about account types.

PHYSICAL RECOVERY AFTER LOCAL EN BLOC RESECTION OF LARGE RECTAL POLYPS: AN ANCILLARY STUDY OF THE RANDOMIZED TRIASSIC TRIAL

Nik Dekkers 1, Matthijs D. Kruizinga 2, Richard Dang 1, Frederik E. Stuurman 3,1, Vasileios Exadaktylos 3, Alexandra Langers 1, jolein van der Kraan 1, Jonathan Lai 4, Leendert H. Oterdoom 2, Peter A. Neijenhuis 5, Els L. van Persijn van Meerten 1, Roel Hompes 6, Pascal G. Doornebosch 7, Marinke Westerterp 4, Barbara A.J. Bastiaansen 6, James Hardwick 1, Jurjen J. Boonstra 1

Affiliations

1 Leiden University Medical Center, Leiden, Netherlands

2 Haga Teaching Hospital, The Hague, Netherlands

3 Centre for Human Drug Research, Leiden, Netherlands

4 Haaglanden Medical Center, The Hague, Netherlands

5 Alrijne Hospital, Leiderdorp, Netherlands

6 Amsterdam University Medical Center, Amsterdam, Netherlands

7 IJsselland Hospital, Capelle aan den IJssel, Netherlands

Summary

AI Generated

In a randomized trial of 40 patients with large rectal polyps, endoscopic submucosal dissection achieved faster physical recovery (median 6.5 days) compared to transanal minimally invasive surgery (median 14.5 days), with post-procedural pain identified as a modifiable factor influencing recovery time.

Median time to physical recovery measured by smartwatch step-count was 6.5 days after ESD versus 14.5 days after TAMIS, a statistically significant difference (p=0.022).
Post-procedural pain scores were similar between techniques in the first week but significantly impacted physical activity, with each pain point increase reducing step count by 14% in both groups.
Higher post-procedural pain was significantly associated with prolonged recovery time (p=0.001), suggesting pain management may be a modifiable target to improve outcomes.
Larger polyp diameter (≥4cm) prolonged recovery after ESD, while female sex and polyps within 1cm of the dentate line prolonged recovery after TAMIS.
This ancillary study of the TRIASSIC randomized trial included 40 patients (mean age 66.7 years) with median polyp size 42.5mm, of which 82.5% were benign and 17.5% were early-stage T1 rectal cancer.

Download PDF

Was this helpful?

Thanks for your feedback.

This summary was generated by an AI large language model based on the content transcript. It is for informational purposes only and should not be considered a substitute for clinical judgment. Always rely on your professional expertise and the full clinical context when making clinical decisions.

Abstract

Introduction

Endoscopic submucosal dissection (ESD) and transanal minimally invasive surgery (TAMIS) are considered standard of care minimally invasive local en bloc resection techniques for larger benign rectal polyps and early-invasive rectal cancer. To optimize post-procedural care for patients, it is important to obtain more insight in the post-procedural physical recovery of both techniques.

Aims & Methods

This is an ancillary study of the multicenter non-inferiority randomized TRIASSIC-trial (Netherlands Trial Register: NL7083) that compares the outcomes of ESD and TAMIS for large (≥20mm) rectal polyps (1). Patients were 1:1 randomized between ESD or TAMIS and monitored with a smartwatch during a 14-day baseline period prior to resection and a 28-day post-procedural recovery period. A mixed-effects model was fitted for physical activity to describe the recovery period. Recovery was defined as reaching ≥90% of the baseline step-count for 2 consecutive days. If patients did not meet this pre-defined definition of recovery within 28 days post-treatment, a recovery time of 30 days was used in the analyses. This study analyzed subjective time to recovery through an end-of-study questionnaire and post-procedural pain through a self-reported pain diary.

Results

A total of 40 patients were included (20 ESD, 20 TAMIS). The mean age was 66.7 years (SD 7.4), 57.5% was male, and median polyp size was 42.5mm (IQR 25). Histological assessment showed a benign polyp in 82.5% and early-stage T1 rectal cancer in 17.5%. Seventeen patients (85%) in the ESD group and 15 patients (75%) in the TAMIS group were physically recovered within the 28-day post-procedural recovery period (p=0.43). The median time to physical recovery was 6.5 days (IQR 18) after ESD and 14.5 days (IQR 21.3) after TAMIS (p=0.022). Subjective time to recovery was 1-2 weeks in 47.5%, 3-4 weeks in 17.5%, and 32.5% did not feel completely recovered within 28 days. There was a significant correlation (Spearman’s rho = 0.66, p<0.001) between the physical (smartwatch) and subjective (end-of-study questionnaire) time to recovery. Post-procedural pain scores in the first week were similar between ESD and TAMIS (p=0.86) and were significantly associated with patients’ level of physical activity (p<0.01); for each point increase in the pain score total step count compared to baseline decreased by 14% after both ESD (95%CI 4-22%) and TAMIS (95%CI 5-22%). Additionally, higher post-procedural pain scores were significantly associated with a prolonged time to recovery (p=0.001). Other factors that were significantly associated with a prolonged time to physical recovery were polyp diameter ≥4cm (only in the ESD group; p=0.003), polyp located ≤1cm from the dentate line, and female sex (only in the TAMIS group, p=0.02 and p=0.03, respectively)

Conclusion

ESD-treated patients have a shorter physical recovery time of ~1 week as compared to ~2 weeks for TAMIS-treated patients. Post-procedural pain is a potentially modifiable factor that significantly influences physical activity and time to physical recovery after ESD and TAMIS.

References

1. Dekkers N, Boonstra JJ, Moons LMG, Hompes R, Bastiaansen BA, Tuynman JB, et al. Transanal minimally invasive surgery (TAMIS) versus endoscopic submucosal dissection (ESD) for resection of non-pedunculated rectal lesions (TRIASSIC study): study protocol of a European multicenter randomised controlled trial. BMC Gastroenterology. 2020;20(1):225.

Disclosure

The TRIASSIC trial is funded by ZonMW (Efficiency program: 852001926) and Applied Medical. Funding bodies had no role in the study design, data collection and analyses, decision to publish, or preparation of this abstract.

Conference

UEG Week Copenhagen 2023

Topics

Colorectal

Submission format

Abstract

Session

Lower GI endoscopic polypectomy (Posters)

Citation

United European Gastroenterology Journal 2023; 11 (Supplement 8)

Published

2023

More Like This:

EFFECT OF SAME-SESSION ENDOSCOPIC ULTRASONOGRAPHY ON ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY IN PANCREATICOBILIARY DISEASES: A RANDOMIZED CONTROLLED TRIAL

Zefeng Xing

ASSOCIATIONS BETWEEN DIASTOLIC AND SYSTOLIC DYSFUNCTION, VALVULAR HEART DISEASE, AND CIRRHOTIC CARDIOMYOPATHY WITH INTRAVASCULAR VOLUME OVERLOAD AFTER ALBUMIN INFUSION IN PATIENTS WITH LIVER CIRRHOSIS

Annalisa Berzigotti

Gastropexy and hybrid PEG/Push PEG Pexact – Small changes lead to better results (Fresenius Kabi MedTech)

DIFFERENTIAL ASSOCIATES OF TWO FACETS OF PARKINSON’S DISEASE, RIGIDITY AND TREMOR, WITH THE FAECAL BACTERIOME, CONTRASTED WITH INFLAMMATORY BOWEL DISEASE

Andre Charlett

Endoscopic therapies for acid

Prakash Gyawali

What can we learn from ADMIRE?

Nuha Yassin

UEG Presentation

New

Share via Email Share on Facebook Share on X Share on LinkedIn Share on Bluesky

EFFECT OF SAME-SESSION ENDOSCOPIC ULTRASONOGRAPHY ON ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY IN PANCREATICOBILIARY DISEASES: A RANDOMIZED CONTROLLED TRIAL

This content is part of Gutflix. Log in with your myUEG account, or create one free, to watch it.

Not sure what you can access? Learn more about account types.

EFFECT OF SAME-SESSION ENDOSCOPIC ULTRASONOGRAPHY ON ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY IN PANCREATICOBILIARY DISEASES: A RANDOMIZED CONTROLLED TRIAL

Zhen Li 1, Yile Zeng 1, Zefeng Xing 1

Affiliations

1 Qilu Hospital of Shandong University, Jinan, China

Summary

AI Generated

Summary is not available for this content yet.

Download PDF

Was this helpful?

Thanks for your feedback.

Abstract

Introduction

Endoscopic Ultrasonography (EUS) is increasingly being used in preoperative examinations in pancreatobiliary diseases for Endoscopic retrograde cholangiopancreatography (ERCP). However, it has never been tested in a randomized trial. This study aims to investigate the clinical value of performing EUS prior to ERCP versus performing conventional ERCP alone, focusing on avoiding unnecessary procedures, ensuring treatment concordance, reducing radiation exposure, and preventing complications.

Aims & Methods

In this single-center, parallel-group randomized controlled trial, patients with pancreaticobiliary diseases and a clear indication for ERCP were enrolled. Using a random number table, participants were assigned to either the EUS+ERCP group or the ERCP alone group. The primary outcomes were the rate of avoided unnecessary ERCP and the concordance rate between actual and initially planned interventional strategies. Secondary outcomes included technical success, difficult cannulation, procedure time, radiation dose, and complications.

Results

A total of 208 patients were randomized (105 to EUS+ERCP, 103 to ERCP alone). In the EUS+ERCP group, ERCP was avoided in 18 patients (17.1%) because EUS findings precluded the need for intervention. Among patients who proceeded to ERCP, the strategy concordance rate was significantly higher in the EUS+ERCP group (78/87, 89.7%) than in the ERCP alone group (74/103, 71.8%) (P = 0.002). The EUS+ERCP group also had significantly lower fluoroscopy time, radiation dose, DAP (Dose area product), and ERCP procedure time (P < 0.05). No significant differences were observed between groups in technical success, difficult cannulation, total procedure time, or complication rates (all P>0.05).

Conclusion

Performing EUS prior to ERCP significantly improves concordance between the interventional strategy and the procedure, safely reduces unnecessary ERCP procedures, and lowers radiation exposure. These findings suggest that pre-procedural EUS should be considered, when feasible, for patients with an indication for ERCP to optimize clinical decision-making.

Event

UEG Week Barcelona 2026

Topics

Radiology & Imaging Hepatobiliary Endoscopy

Submission format

Abstract

Session

Endoscopy: Taming the biliary tree

Citation

2026: United European Gastroenterology Journal 2026; 14 (S1)

Published

2026

More Like This:

EFFECT OF SAME-SESSION ENDOSCOPIC ULTRASONOGRAPHY ON ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY IN PANCREATICOBILIARY DISEASES: A RANDOMIZED CONTROLLED TRIAL

Zefeng Xing

ASSOCIATIONS BETWEEN DIASTOLIC AND SYSTOLIC DYSFUNCTION, VALVULAR HEART DISEASE, AND CIRRHOTIC CARDIOMYOPATHY WITH INTRAVASCULAR VOLUME OVERLOAD AFTER ALBUMIN INFUSION IN PATIENTS WITH LIVER CIRRHOSIS

Annalisa Berzigotti

Gastropexy and hybrid PEG/Push PEG Pexact – Small changes lead to better results (Fresenius Kabi MedTech)

DIFFERENTIAL ASSOCIATES OF TWO FACETS OF PARKINSON’S DISEASE, RIGIDITY AND TREMOR, WITH THE FAECAL BACTERIOME, CONTRASTED WITH INFLAMMATORY BOWEL DISEASE

Andre Charlett

Endoscopic therapies for acid

Prakash Gyawali

What can we learn from ADMIRE?

Nuha Yassin

UEG Presentation

New

Share via Email Share on Facebook Share on X Share on LinkedIn Share on Bluesky

ASSOCIATIONS BETWEEN DIASTOLIC AND SYSTOLIC DYSFUNCTION, VALVULAR HEART DISEASE, AND CIRRHOTIC CARDIOMYOPATHY WITH INTRAVASCULAR VOLUME OVERLOAD AFTER ALBUMIN INFUSION IN PATIENTS WITH LIVER CIRRHOSIS

This content is part of Gutflix. Log in with your myUEG account, or create one free, to watch it.

Not sure what you can access? Learn more about account types.

ASSOCIATIONS BETWEEN DIASTOLIC AND SYSTOLIC DYSFUNCTION, VALVULAR HEART DISEASE, AND CIRRHOTIC CARDIOMYOPATHY WITH INTRAVASCULAR VOLUME OVERLOAD AFTER ALBUMIN INFUSION IN PATIENTS WITH LIVER CIRRHOSIS

Fabio Brazerol 1, Daniel Segna 1, Jaime Bosch 1,2, Stefano De Marchi 1, Annalisa Berzigotti 1

Affiliations

1 Inselspital Bern and University of Bern, Bern, Switzerland, Bern, Switzerland

2 University of Bern, Bern, Switzerland

Summary

AI Generated

Summary is not available for this content yet.

Download PDF

Was this helpful?

Thanks for your feedback.

Abstract

Introduction

Current guidelines recommend intravenous (IV) albumin as a treatment of various complications of decompensated cirrhosis, but recent data point towards clinically relevant volume overload post-infusion in this population. A prospective cohort study assessing point-of-care ultrasound (POCUS) of the inferior vena cava (IVC) found potentially severe intravascular volume overload in almost 20% of patients after albumin. However, it is still unknown whether underlying cardiac function may predict post-infusion hypervolemia and short to mid-term clinical outcomes.

Aims & Methods

In this retrospective analysis of 54 individual adults with cirrhosis receiving IV albumin, we assessed associations between transthoracic echocardiography (TTE) parameters, IVC-derived potential volume overload using POCUS, and clinical outcomes during a period of 6 months. TTE parameters were extracted from examinations within 3 months of inclusion. Any volume overload was defined as maximum IVC diameter (IVC_max) >2.1cm and IVC collapsibility index (IVCCI) < 50%; severe overload as IVC_max > 2.1cm and IVCCI < 20%. Potential associations between TTE parameters and any or severe volume overload and clinical outcomes up to 6 months (p<0.10) in univariable regression analyses were consequently analyzed in multivariable regression models adjusting for age, sex, and model of end stage liver disease (MELD).

Results

Among 76 POCUS measurements from 54 patients (female 22.4%, median age 62 years, median MELD 15), any degree of volume overload occurred in 51.3% and severe overload in 22.4% after albumin infusion. The median right ventricular-right atrial gradient (RVRA) was 23 mmHg (interquartile range [IQR] 20-28), while cirrhotic cardiomyopathy (CCM) was present in 15.8% (12/76) and diastolic dysfunction (DD ≥ Grade 1) in 36.1% (26/76). In multivariable analyses, higher RVRA levels were independently associated with any volume overload (odds ratio [OR] 1.83 per 5 mmHg increase, 95% confidence interval [CI] 1.09–3.10; p=0.023). This was further supported by a threshold analysis, showing that RVRA ≥ 25 mmHg significantly increased the risk of any volume overload (OR 4.30, 95%CI 1.21-15.31; p=0.024). Sensitivity analyses restricted to individual patients (n=54) confirmed these findings. Regarding clinical outcomes, we only included the first examination. High rates of liver-related events such as acute kidney injury (55.6%), spontaneous bacterial peritonitis (SBP; 22.2%), hepatic encephalopathy (HE; 29.6%) and mortality (29.6%) were observed within 6 months from baseline. In multivariable models, DD was associated with SBP at 3 months (OR 20.78, 95%CI 1.76–245.30; p=0.016). Furthermore, CCM according to the 2019 CCM consortium definitions was significantly associated with HE at 3 months (OR 6.12, 95%CI 1.30–28.72; p=0.022), but this effect did not persist until 6 months from baseline.

Conclusion

This study provides initial evidence of an association between RVRA and volume overload following albumin therapy, potentially reflecting an increased susceptibility to fluid challenge in conditions associated with subclinically elevated pulmonary arterial pressure in patients with decompensated cirrhosis. Although transient associations were observed between TTE parameters and liver-related outcomes, these findings require confirmation. Furthermore, clinically inapparent DD and CCM are a common finding in this population, while their prognostic role deserves further exploration in larger prospective cohort studies.

Disclosure

FB and SdM have nothing to declare. DS reports travelling fees from GIlead and Falk. AB serves as consultant and/or speaker for Boehringer Ingelheim, GE HealthCare; Hologic; W. L. Gore & Associates. JB was a consultant for AstraZeneca, NovoNordisk, Boehringer Ingelheim and Resolution Therapeutics.

Event

UEG Week Barcelona 2026

Topics

Mechanisms & Personalised Medicine Radiology & Imaging Hepatobiliary

Submission format

Abstract

Session

Liver cirrhosis: A cirrhotic conundrum - Diagnosis and evaluation

Citation

2026: United European Gastroenterology Journal 2026; 14 (S1)

Published

2026

More Like This:

EFFECT OF SAME-SESSION ENDOSCOPIC ULTRASONOGRAPHY ON ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY IN PANCREATICOBILIARY DISEASES: A RANDOMIZED CONTROLLED TRIAL

Zefeng Xing

ASSOCIATIONS BETWEEN DIASTOLIC AND SYSTOLIC DYSFUNCTION, VALVULAR HEART DISEASE, AND CIRRHOTIC CARDIOMYOPATHY WITH INTRAVASCULAR VOLUME OVERLOAD AFTER ALBUMIN INFUSION IN PATIENTS WITH LIVER CIRRHOSIS

Annalisa Berzigotti

Gastropexy and hybrid PEG/Push PEG Pexact – Small changes lead to better results (Fresenius Kabi MedTech)

DIFFERENTIAL ASSOCIATES OF TWO FACETS OF PARKINSON’S DISEASE, RIGIDITY AND TREMOR, WITH THE FAECAL BACTERIOME, CONTRASTED WITH INFLAMMATORY BOWEL DISEASE

Andre Charlett

Endoscopic therapies for acid

Prakash Gyawali

What can we learn from ADMIRE?

Nuha Yassin

UEG Presentation

New

Share via Email Share on Facebook Share on X Share on LinkedIn Share on Bluesky

Gastropexy and hybrid PEG/Push PEG Pexact – Small changes lead to better results (Fresenius Kabi MedTech)

This content is part of Gutflix. Log in with your myUEG account, or create one free, to watch it.

Not sure what you can access? Learn more about account types.

Gastropexy and hybrid PEG/Push PEG Pexact – Small changes lead to better results (Fresenius Kabi MedTech)

Summary

AI Generated

Summary is not available for this content yet.

Download PDF

Was this helpful?

Thanks for your feedback.

Abstract

Event

UEG Week Barcelona 2026

Topics

Nurses

Session

New trends and developments in endoscopic techniques

Citation

2026: United European Gastroenterology Journal 2026; 14 (S1)

Published

2026

More Like This:

EFFECT OF SAME-SESSION ENDOSCOPIC ULTRASONOGRAPHY ON ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY IN PANCREATICOBILIARY DISEASES: A RANDOMIZED CONTROLLED TRIAL

Zefeng Xing

ASSOCIATIONS BETWEEN DIASTOLIC AND SYSTOLIC DYSFUNCTION, VALVULAR HEART DISEASE, AND CIRRHOTIC CARDIOMYOPATHY WITH INTRAVASCULAR VOLUME OVERLOAD AFTER ALBUMIN INFUSION IN PATIENTS WITH LIVER CIRRHOSIS

Annalisa Berzigotti

Gastropexy and hybrid PEG/Push PEG Pexact – Small changes lead to better results (Fresenius Kabi MedTech)

DIFFERENTIAL ASSOCIATES OF TWO FACETS OF PARKINSON’S DISEASE, RIGIDITY AND TREMOR, WITH THE FAECAL BACTERIOME, CONTRASTED WITH INFLAMMATORY BOWEL DISEASE

Andre Charlett

Endoscopic therapies for acid

Prakash Gyawali

What can we learn from ADMIRE?

Nuha Yassin

UEG Poster

New

Standard Poster

Share via Email Share on Facebook Share on X Share on LinkedIn Share on Bluesky

This content is part of Gutflix. Log in with your myUEG account, or create one free, to watch it.

Not sure what you can access? Learn more about account types.

DIFFERENTIAL ASSOCIATES OF TWO FACETS OF PARKINSON’S DISEASE, RIGIDITY AND TREMOR, WITH THE FAECAL BACTERIOME, CONTRASTED WITH INFLAMMATORY BOWEL DISEASE

Jennifer Yick 1, Kieran Baker 1, Chianna Umamahesan 1, David Taylor 1, Melvyn Smith 1, Christopher Jordan 2, Bu Hayee 3, Polychronis Pavlidis 3, Julian R Marchesi 2, Benjamin H Mullish 2, Sylvia Dobbs 1, Richard Dobbs 1, Andre Charlett 4

Affiliations

1 Kings College London, London, United Kingdom

2 Imperial College London, London, United Kingdom

3 Kings College Hospital, London, United Kingdom

4 UKHSA, London, United Kingdom

Summary

AI Generated

Summary is not available for this content yet.

Download PDF

Was this helpful?

Thanks for your feedback.

Abstract

Introduction

Maintenance laxative is associated with stemming of temporal increase in rigidity in Parkinson’s disease (PD), indicative of underlying gut microbiome perturbation.¹ Longer colonic transit has been linked to faecal short-chain-fatty acids (SCFAs) deficit outside PD, but not (possibly due to laxatives) within.²We question whether a deficit in microbial SCFA producers might drive rigidity. Furthermore, is tremor, a dissimilar PD facet (phenotypic cluster analysis), unrelated to SCFA producers? Indeed, is the pathogenesis of different PD phenomena masked by using PD status as outcome. We contrast our findings with those for PD and Inflammatory Bowel Disease (IBD)³status.

Aims & Methods

We analyse bacteriome predictor hierarchy for rigidity and tremor displacement, objectively quantified across diagnostic divide,¹ using PacBio full length 16S rRNA gene sequencing in 75 participants with diagnosed PD, 112 without, with yearly repetition of stool samples (306). At each taxonomic rank, mixed effects linear regression models were used after logarithmic transformation of outcome. Measurement conditions and demographic factors were included as predictors, with subject as a random intercept. Initially, single variable analyses were performed for each taxon, considering linear, and first and second order fractional polynomials. Candidates were selected for consideration in multivariable models using p-values, selecting predictors and simplifying their relationship to outcome where indicated. Finally, excluded taxa were added into the model and any found important included.

Results

Predictor hierarchy approach revealed clear patterns along taxonomic branches from phylum to order for these two PD facets.
There was a protective association for phylum Desulfobactererota for rigidity, with an escalation to 21% decrease above 50^th centile of abundance range, and a non-monotonic association for tremor with 49% decrease above 75^th centile, but proceeded by a 28% increase upto 50^th centile. Similar associations were traced to order level,
Phylum Bacillota also had a protective association for rigidity with 36% decrease across abundance range. Its class Clostrida showed a 47% decrease, and orders Peptostreptococcales–Tissierellales and Lachnospirales 29 and 51%, respectively. For tremor, an unconvincing association was seen with Bacillota, but Clostridia had a protective association with a 15% decrease. Its only order associated was Monoglobales with 39% decrease in tremor at abundance upto 50^th centile, plateauing after in a non-monotonic relationship.
In contrast, in systematic review, the above taxa were not reported as associated with PD (33 papers) or IBD (23) status. However, within the Bacillota lineage, family Lachnospiraceae and genus Peptostreptococcus had, respectively, a protective association with IBD and a risk with Crohn’s disease.³

Conclusion

The non‑parallel progression of PD facets fits with different drivers and mediators. Bacillota predictors of rigidity are typical of their class Clostridia: abundant, well‑characterized obligate anaerobes, known to produce SCFAs and other fermentation products. In contrast, tremor predictor, Monoglobales, does not share the defining anaerobic feature, and currently its metabolite profile is unknown.
Regression framework used ensures that disease facets are outcome variables and confounded associations identified. Permutation multivariate analysis of variance, typically used in published literature, cannot account for confounding and is incompatible with causal frameworks.

References

Augustin A, Guennec AL, Umamahesan C, et al.Faecal metabolite deficit, gut inflammation and diet in Parkinson's disease: Integrative analysis indicates inflammatory response syndrome. Clin Transl Med. 2023;13(1):e1152. doi: 10.1002/ctm2.1152.
Augustin AD, Charlett A, Weller C, et al. Quantifying rigidity of Parkinson's disease in relation to laxative treatment: a service evaluation. Br J Clin Pharmacol. 2016;82(2):441-50. doi: 10.1111/bcp.12967.
Khan I, Ullah N, Zha L, et al. Alteration of Gut Microbiota in Inflammatory Bowel Disease (IBD): Cause or Consequence? IBD Treatment Targeting the Gut Microbiome. Pathogens. 2019;8(3):126. doi: 10.3390/pathogens8030126.

Conference

UEG Week Barcelona 2026

Topics

Colorectal

Submission format

Abstract

Session

Gut microbiome: From bench to bedside (Posters)

Citation

2026: United European Gastroenterology Journal 2026; 14 (S1)

Published

2026

More Like This:

EFFECT OF SAME-SESSION ENDOSCOPIC ULTRASONOGRAPHY ON ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY IN PANCREATICOBILIARY DISEASES: A RANDOMIZED CONTROLLED TRIAL

Zefeng Xing

ASSOCIATIONS BETWEEN DIASTOLIC AND SYSTOLIC DYSFUNCTION, VALVULAR HEART DISEASE, AND CIRRHOTIC CARDIOMYOPATHY WITH INTRAVASCULAR VOLUME OVERLOAD AFTER ALBUMIN INFUSION IN PATIENTS WITH LIVER CIRRHOSIS

Annalisa Berzigotti

Gastropexy and hybrid PEG/Push PEG Pexact – Small changes lead to better results (Fresenius Kabi MedTech)

DIFFERENTIAL ASSOCIATES OF TWO FACETS OF PARKINSON’S DISEASE, RIGIDITY AND TREMOR, WITH THE FAECAL BACTERIOME, CONTRASTED WITH INFLAMMATORY BOWEL DISEASE

Andre Charlett

Endoscopic therapies for acid

Prakash Gyawali

What can we learn from ADMIRE?

Nuha Yassin

UEG Presentation

New

Share via Email Share on Facebook Share on X Share on LinkedIn Share on Bluesky

This content is part of Gutflix. Log in with your myUEG account, or create one free, to watch it.

Not sure what you can access? Learn more about account types.

Endoscopic therapies for acid

Prakash Gyawali 1

Affiliations

1 Washington University School Of Medicine, St. Louis, United States of America

Summary

AI Generated

Summary is not available for this content yet.

Download PDF

Was this helpful?

Thanks for your feedback.

Abstract

Event

UEG Week Barcelona 2026

Topics

Endoscopy Oesophagus

Session

Gastro-oesophageal reflux: How to keep the acid down?

Citation

2026: United European Gastroenterology Journal 2026; 14 (S1)

Published

2026

More Like This:

EFFECT OF SAME-SESSION ENDOSCOPIC ULTRASONOGRAPHY ON ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY IN PANCREATICOBILIARY DISEASES: A RANDOMIZED CONTROLLED TRIAL

Zefeng Xing

ASSOCIATIONS BETWEEN DIASTOLIC AND SYSTOLIC DYSFUNCTION, VALVULAR HEART DISEASE, AND CIRRHOTIC CARDIOMYOPATHY WITH INTRAVASCULAR VOLUME OVERLOAD AFTER ALBUMIN INFUSION IN PATIENTS WITH LIVER CIRRHOSIS

Annalisa Berzigotti

Gastropexy and hybrid PEG/Push PEG Pexact – Small changes lead to better results (Fresenius Kabi MedTech)

DIFFERENTIAL ASSOCIATES OF TWO FACETS OF PARKINSON’S DISEASE, RIGIDITY AND TREMOR, WITH THE FAECAL BACTERIOME, CONTRASTED WITH INFLAMMATORY BOWEL DISEASE

Andre Charlett

Endoscopic therapies for acid

Prakash Gyawali

What can we learn from ADMIRE?

Nuha Yassin

UEG Presentation

New

Share via Email Share on Facebook Share on X Share on LinkedIn Share on Bluesky

This content is part of Gutflix. Log in with your myUEG account, or create one free, to watch it.

Not sure what you can access? Learn more about account types.

What can we learn from ADMIRE?

Nuha Yassin 1

Affiliations

1 St Mark'S Hospital, London, London, United Kingdom

Summary

AI Generated

Summary is not available for this content yet.

Download PDF

Was this helpful?

Thanks for your feedback.

Abstract

Event

UEG Week Barcelona 2026

Topics

IBD

Session

What can we learn from ‘failed’ IBD trials?

Citation

2026: United European Gastroenterology Journal 2026; 14 (S1)

Published

2026

More Like This:

EFFECT OF SAME-SESSION ENDOSCOPIC ULTRASONOGRAPHY ON ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY IN PANCREATICOBILIARY DISEASES: A RANDOMIZED CONTROLLED TRIAL

Zefeng Xing

ASSOCIATIONS BETWEEN DIASTOLIC AND SYSTOLIC DYSFUNCTION, VALVULAR HEART DISEASE, AND CIRRHOTIC CARDIOMYOPATHY WITH INTRAVASCULAR VOLUME OVERLOAD AFTER ALBUMIN INFUSION IN PATIENTS WITH LIVER CIRRHOSIS

Annalisa Berzigotti

Gastropexy and hybrid PEG/Push PEG Pexact – Small changes lead to better results (Fresenius Kabi MedTech)

DIFFERENTIAL ASSOCIATES OF TWO FACETS OF PARKINSON’S DISEASE, RIGIDITY AND TREMOR, WITH THE FAECAL BACTERIOME, CONTRASTED WITH INFLAMMATORY BOWEL DISEASE

Andre Charlett

Endoscopic therapies for acid

Prakash Gyawali

What can we learn from ADMIRE?

Nuha Yassin